FDA Slams Citizen Petition: Harsh Language, FTC Referral Suggest Tougher Stance On ANDA Delay Tactics

 
• By Brenda Sandburg
  
US FDA denies Par's citizen petition (photo illustration|Alamy image)
US FDA denies Par's citizen petition challenging vasopressin ANDA • Source: Nielsen Hobbs; the Pink Sheet|Alamy image

More from Generics

More from Biosimilars & Generics